Healthcare NSE: APOLLOHOSP

Apollo Hospitals Financial Statements, P/E Ratio & ROE Valuation

Apollo Hospitals (APOLLOHOSP) — Medical Care Facilities

₹8,974.50 INR
▲ ₹64.50 (+0.72%)

Apollo Hospitals Financial Statements & Valuation Multiples

✨ Financials & Valuation Analysis

Apollo Hospitals commands a premium valuation with a P/E of 66.70507, supported by high market dominance and profitability expectations.

P/E Ratio (TTM) 66.70507
Forward P/E 41.87269
Price-to-Book (P/B) 13.611628
Return on Equity (ROE) 21.5%
Profit Margin 7.7%
Operating Margin 12.06%
EPS (TTM) ₹134.54
Enterprise Value ₹1.37 Lakh Cr

Financial Health & Profitability Breakdown for Apollo Hospitals

A comprehensive review of Apollo Hospitals reveals an ROE of 21.5% and operating profitability margins of 12.06%. Apollo Hospitals maintains high capital efficiency with an ROE of 21.5% and operating margins of 12.06%, demonstrating robust cash generation capabilities.

Evaluating valuation metrics, Apollo Hospitals maintains a Price-to-Earnings ratio of 66.70507 and a Price-to-Book multiple of 13.611628. These valuation metrics, combined with an Enterprise Value of ₹1.37 Lakh Cr, provide essential indicators for fundamentally driven stock selection in India's Healthcare sector.

Frequently Asked Questions

What is Apollo Hospitals P/E ratio and Price-to-Book (P/B) ratio?
Apollo Hospitals trades at a trailing P/E of 66.70507, a Forward P/E of 41.87269, and a P/B ratio of 13.611628.
What is Apollo Hospitals Return on Equity (ROE)?
Apollo Hospitals reports a Return on Equity (ROE) of 21.5%, reflecting shareholder capital efficiency.
What are Apollo Hospitals profit margin and operating margin?
Apollo Hospitals maintains a net profit margin of 7.7% and an operating margin of 12.06%.
What is Apollo Hospitals Enterprise Value and EBITDA multiplier?
Apollo Hospitals has an Enterprise Value of ₹1.37 Lakh Cr and reported earnings per share (TTM EPS) of ₹134.54.

Explore Similar Healthcare Stocks